Additionally, miR-146a is upregulated in individuals with T1D, targeting inflammation-related genes such as tumor necrosis factor receptor-associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 1 (IRAK1), thereby amplifying inflammatory responses. Here, IRAK1 is linked to type 1 diabetes mellitus.